National Academies Press: OpenBook
« Previous: References
Suggested Citation:"Appendix A: Health Affairs Blog Posts." National Academies of Sciences, Engineering, and Medicine. 2022. Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26349.
×

Appendix A

Health Affairs Blog Posts

The blog posts associated with the Envisioning a Transformed Clinical Trials Enterprise for 2030 virtual workshop (listed below) are available at https://www.healthaffairs.org/topic/ss170 (accessed July 1, 2021).1

  • Transforming Clinical Trials: A New Vision for 2030. In this blog post, Marilyn Metcalf and Rob Weker lay out their vision for person-centered clinical trials in the year 2030 and provide an outline of how to get there.
  • Driving Towards More Inclusive Clinical Trials by 2030: Action Without Strategy Is Aimless, Strategy Without Action Is Powerless. Silas Buchanan lays out a vision for a clinical trials enterprise that benefits from diversity in its participants and workforce through ongoing community engagement.
  • The Future of Clinical Trials: How Will New Technologies Affect the Lives of Participants? Andy Coravos, Eric Perakslis, and Sam Roosz envision how the lives of four fictional individuals could be changed with the integration of technologies into the clinical trials enterprise.
  • A Future of Trusted Clinical Trials: Communication Strategies to Encourage Trust and Transparency. Brian Southwell discusses the

___________________

1 These Health Affairs blog posts represent the opinions of the authors and do not necessarily represent the views of any one organization; the Forum on Drug Discovery, Development, and Translation; or the National Academies, and were not subjected to the review procedures of, nor are a publication or product of, the National Academies.

Suggested Citation:"Appendix A: Health Affairs Blog Posts." National Academies of Sciences, Engineering, and Medicine. 2022. Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26349.
×
  • importance of fostering trust and transparency in the clinical trials enterprise for improving the person-centeredness and relevance of clinical trial research.
  • Clinical Trials in Crisis: Building on COVID-19’s Lessons Toward a Better Future. Esther Krofah, Steven Galson, Robert Califf, and Gregory Simon synthesize three central categories emerging from these workshop discussions for future improvement—engagement, efficiency, and coordination—and issue a call to action.
Suggested Citation:"Appendix A: Health Affairs Blog Posts." National Academies of Sciences, Engineering, and Medicine. 2022. Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26349.
×
Page 81
Suggested Citation:"Appendix A: Health Affairs Blog Posts." National Academies of Sciences, Engineering, and Medicine. 2022. Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop. Washington, DC: The National Academies Press. doi: 10.17226/26349.
×
Page 82
Next: Appendix B: Speaker and Moderator Biographies »
Envisioning a Transformed Clinical Trials Enterprise for 2030: Proceedings of a Workshop Get This Book
×
Buy Paperback | $30.00 Buy Ebook | $24.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

The evolution of health care is expanding the possibilities for integration of clinical research into the continuum of clinical care; new approaches are enabling the collection of data in real-world settings; and new modalities, such as digital health technologies and artificial intelligence applications, are being leveraged to overcome challenges and advance clinical research. At the same time, the clinical research enterprise is strained by rising costs, varying global regulatory and economic landscapes, increasing complexity of clinical trials, barriers to recruitment and retention of research participants, and a clinical research workforce that is under tremendous demands.

Looking ahead to 2030, the Forum on Drug Discovery, Development, and Translation of the National Academies of Sciences, Engineering, and Medicine convened a public workshop for stakeholders from across the drug research and development life cycle to reflect on the lessons learned over the past 10 years and consider opportunities for the future. The workshop was designed to consider goals and priority action items that could advance the vision of a 2030 clinical trials enterprise that is more efficient, effective, person-centered, inclusive, and integrated into the health care delivery system so that outcomes and experiences for all stakeholders are improved. This Proceedings of a Workshop summarizes the presentations and discussions that took place during the four-part virtual public workshop held on January 26, February 9, March 24, and May 11, 2021.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!